An Introduction to Neurosurgery
Neurosurgery, one of the most innovative, fastest advancing specialties, is broad in that it encompasses surgery of the CNS (brain and spinal cord), as well as peripheral nerves to the entire body. It serves as a tool for both diagnosis and treatment of patients with injury to, or diseases/disorders of the nervous system. Surgical advances continue in areas such as craniotomy, brain and spinal tumours, endovascular procedures, epilepsy, movement disorders, paediatrics, traumatic injuries, ventricular shunts and more.
Browse our gallery of video highlights and short articles from the conference hub, providing latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Optimal Approaches to Skin Preparation Prior to Neurosurgery
US Neurology. 2020:16(1):50–3 DOI: https://doi.org/10.17925/USN.2020.16.1.50
Infections and their prevention have long been a significant concern for surgeons around the world. Surgical site infections (SSIs) represent a considerable burden for both patients and providers alike, as they often result in significant morbidity and mortality, as well as high costs to healthcare systems. In the United States, SSIs have been identified as […]
High-definition Fiber Tractography as Surgical Adjunct for Management of Hyper-eloquent Brain Lesions
US Neurology. 2018;14(2):78–9 DOI: https://doi.org/10.17925/USN.2018.14.2.78
Cerebral cavernous malformations are commonly found in deep regions of the brain, such as the thalamus and brainstem.1 While posing a significant risk of hemorrage,2 they also present a surgical challenge as the rates of morbidity and mortality are high.1,3 In patients with brain blood vessel malformations, planning the safest approach to surgery is critical. […]
Updated American Academy Guidelines on the Use of Disease-modifying Therapies in Multiple Sclerosis—What’s New?
US Neurology. 2018;14(2):76–7 DOI: https://doi.org/10.17925/USN.2018.14.2.76
Recently released guidelines on the use of disease-modifying therapies (DMTs) in patients with multiple sclerosis (MS) include guidance on starting, switching, and stopping treatment. The guidelines, which were produced by a multidisciplinary panel and endorsed by the Multiple Sclerosis Association of America and the National Multiple Sclerosis Society, were presented at the American Academy of […]
Importance of Cognitive Screening and Management in Multiple Sclerosis Care—Reflection on the Recent Recommendations
US Neurology. 2018;14(2):73–5 DOI: https://doi.org/10.17925/USN.2018.14.2.73
The importance of recognizing and including cognition as a key factor to consider when ensuring comprehensive care for individuals with multiple sclerosis (MS) cannot be over emphasized. Unfortunately, despite it being accepted as a common symptom, cognitive function in MS is still not openly discussed, routinely assessed, or optimally treated. In an expert interview, Rosalind […]
Data Sharing in Alzheimer’s Disease Research
US Neurology. 2018;14(2):68–70 DOI: https://doi.org/10.17925/USN.2018.14.2.68
There has been an explosion of data in the field of Alzheimer’s disease (AD), not only from clinical studies but also studies that generate hypotheses and opportunities that may accelerate drug development. In order to make optimal use of these data, scientists must share findings across organizations and countries. While many researchers recognize the […]
Highlights from the Alzheimer’s Association International Conference—AAIC 2018
US Neurology. 2018;14(2):66–7 DOI: https://doi.org/10.17925/USN.2018.14.2.66
This year, the Alzheimer’s Association International Conference (AAIC) took place in Chicago, IL, US, July 22–26, 2018. During this major annual international meeting dedicated to the advancement of Alzheimer’s disease (AD) and dementia science, an impressive array of the world’s leading scientists, clinical researchers, rising-star investigators, clinicians, and the care research community come together […]
Cerebral Dural Arteriovenous Fistulas—an Update on Pathophysiology, Natural History and Treatment
US Neurology, 2017;13(1):47–9 DOI: https://doi.org/10.17925/USN.2017.13.01.47
Dural arteriovenous fistulas (dAVF)s are unique to the neuraxis as the arteriovenous shunt site is contained within the dural leaflets. They may be discovered incidentally or in a workup of a variety of potential neurological sequelae, including pulsatile tinnitus, ocular symptoms, focal neurologic deficits as a result of venous hypertension or even intracranial hemorrhage.1–7 Symptoms […]
Deep Brain Stimulation for Tourette Syndrome
Dr. Wei Hu, a Clinical Movement Disorders Fellow from the Neurology Department at the University of Florida and formerly at Mayo Clinic in Rochester, MN, gives hope in his article appearing in the November 2014 issue of Mayo Clinic Proceedings, to patients with refractory Tourrette syndrome.
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!